{"title":"抗凝血酶III刺激培养大鼠肝窦内皮细胞产生前列腺素I2","authors":"Hiromasa Ohira, Katsutoshi Obara, Masahito Kuroda, Jun Tojo, Hironobu Ochiai, Masae Kokubun, Masayuki Miyata, Tomoe Nishimaki, Reiji Kasukawa","doi":"10.1016/S0928-4346(96)00332-5","DOIUrl":null,"url":null,"abstract":"<div><p>We examined the production of prostanoids, specifically prostaglandin (PG) I<sub>2</sub> and thromboxane (TX) A<sub>2</sub>, in cultured rat hepatic sinusoidal endothelial cells treated with antithrombin (AT) III. When cells were treated for 3 h with various concentration of AT III, production of 6-keto-PGF<sub>1α</sub> (a stable metabolite of PG I<sub>2</sub>) increased significantly and in a dose-dependent manner, compared with production by untreated cells. In terms of kinetics, significant increases were noted at 3 h (20.13 ± 1.38 pg/ml), 4 h (21.23 ± 0.63 pg/ml) and 24 h (36.58 ± 4.93 pg/ml) with AT III (300 μg/ml) stimulation, compared with production by the untreated cells (10.29 ± 1.21, 10.34 ± 1.66 and 22.64 ± 2.59 pg/ml, respectively). Moreover, this production was significantly reduced with increasing concentrations of heparin. On the other hand, TX B<sub>2</sub> (a stable metabolite of TX A<sub>2</sub>) production was unaffected by AT III treatment. These data suggest that AT III may ameliorate the liver damage or disturbances in the sinusoidal microcirculation by stimulating the PG I<sub>2</sub> production of hepatic sinusoidal endothelial cells.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1996-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00332-5","citationCount":"0","resultStr":"{\"title\":\"Antithrombin III stimulates prostaglandin I2 production by cultured rat hepatic sinusoidal endothelial cells\",\"authors\":\"Hiromasa Ohira, Katsutoshi Obara, Masahito Kuroda, Jun Tojo, Hironobu Ochiai, Masae Kokubun, Masayuki Miyata, Tomoe Nishimaki, Reiji Kasukawa\",\"doi\":\"10.1016/S0928-4346(96)00332-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>We examined the production of prostanoids, specifically prostaglandin (PG) I<sub>2</sub> and thromboxane (TX) A<sub>2</sub>, in cultured rat hepatic sinusoidal endothelial cells treated with antithrombin (AT) III. When cells were treated for 3 h with various concentration of AT III, production of 6-keto-PGF<sub>1α</sub> (a stable metabolite of PG I<sub>2</sub>) increased significantly and in a dose-dependent manner, compared with production by untreated cells. In terms of kinetics, significant increases were noted at 3 h (20.13 ± 1.38 pg/ml), 4 h (21.23 ± 0.63 pg/ml) and 24 h (36.58 ± 4.93 pg/ml) with AT III (300 μg/ml) stimulation, compared with production by the untreated cells (10.29 ± 1.21, 10.34 ± 1.66 and 22.64 ± 2.59 pg/ml, respectively). Moreover, this production was significantly reduced with increasing concentrations of heparin. On the other hand, TX B<sub>2</sub> (a stable metabolite of TX A<sub>2</sub>) production was unaffected by AT III treatment. These data suggest that AT III may ameliorate the liver damage or disturbances in the sinusoidal microcirculation by stimulating the PG I<sub>2</sub> production of hepatic sinusoidal endothelial cells.</p></div>\",\"PeriodicalId\":13746,\"journal\":{\"name\":\"International Hepatology Communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0928-4346(96)00332-5\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Hepatology Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0928434696003325\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Hepatology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928434696003325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Antithrombin III stimulates prostaglandin I2 production by cultured rat hepatic sinusoidal endothelial cells
We examined the production of prostanoids, specifically prostaglandin (PG) I2 and thromboxane (TX) A2, in cultured rat hepatic sinusoidal endothelial cells treated with antithrombin (AT) III. When cells were treated for 3 h with various concentration of AT III, production of 6-keto-PGF1α (a stable metabolite of PG I2) increased significantly and in a dose-dependent manner, compared with production by untreated cells. In terms of kinetics, significant increases were noted at 3 h (20.13 ± 1.38 pg/ml), 4 h (21.23 ± 0.63 pg/ml) and 24 h (36.58 ± 4.93 pg/ml) with AT III (300 μg/ml) stimulation, compared with production by the untreated cells (10.29 ± 1.21, 10.34 ± 1.66 and 22.64 ± 2.59 pg/ml, respectively). Moreover, this production was significantly reduced with increasing concentrations of heparin. On the other hand, TX B2 (a stable metabolite of TX A2) production was unaffected by AT III treatment. These data suggest that AT III may ameliorate the liver damage or disturbances in the sinusoidal microcirculation by stimulating the PG I2 production of hepatic sinusoidal endothelial cells.